INDV
Indivior PLC Ordinary SharesNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$4.61B
P/E Ratio
19.30
EPS
$2.02
Beta
1.20
52W High
$40.02
52W Low
$10.63
50-Day MA
$32.08
200-Day MA
$29.41
Dividend Yield
—
Profit Margin
19.50%
Forward P/E
12.17
PEG Ratio
—
About Indivior PLC Ordinary Shares
Indivior PLC, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company is headquartered in North Chesterfield, Virginia.
Fundamentals
| Revenue (TTM) | $1.29B |
| Gross Profit (TTM) | $1.10B |
| EBITDA | $467.00M |
| Operating Margin | 43.50% |
| Return on Equity | 12.20% |
| Return on Assets | 22.30% |
| Revenue/Share (TTM) | $10.29 |
| Book Value | $-1.19 |
| Price-to-Book | 145.56 |
| Price-to-Sales (TTM) | 3.57 |
| EV/Revenue | 3.791 |
| EV/EBITDA | 13.82 |
| Quarterly Earnings Growth (YoY) | 82.00% |
| Quarterly Revenue Growth (YoY) | 19.20% |
| Shares Outstanding | $118.20M |
| Float | $102.99M |
| % Insiders | 1.40% |
| % Institutions | 99.99% |
Historical Volatility
HV 10-Day
41.98%
HV 20-Day
48.51%
HV 30-Day
47.20%
HV 60-Day
42.65%
HV Rank
65.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($49.83 target)
1
Strong Buy5
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026